— Know what they know.
Not Investment Advice
Asset Manager ← All Institutions

venBio Partners LLC

Q1 2026 · Filed 2026-05-15
Market Value
$149M
+70.8%
Holdings
5
New Purchases
0
Added To
1
Closed
0
Reduced
2
Top 10 Concentration
100.0%
Turnover
0.0%

Top Buys (by % of Portfolio)

SymbolCur %Prior %Chg %Value
ALMS 66.73% 51.51% +15.22% $100M
ALXO 17.28% 12.52% +4.76% $26M

Top Sells (by % of Portfolio)

SymbolCur %Prior %Chg %Value
HRMY 9.17% 20.91% -11.75% $14M
LYEL 4.53% 11.87% -7.34% $7M
ARTV 2.29% 3.18% -0.89% $3M

Sector Allocation Over Time

Market Cap Concentration

TierHoldingsValueWeight
Mid Cap 1 $14M 9.2%
Small Cap 2 $103M 69.0%
Micro Cap 2 $33M 21.8%

Portfolio Analytics

Avg Market Cap
$773M
Median Market Cap
$334M
Avg P/E
12.7
Median P/E
12.7
Avg Dividend Yield
—%
Avg Beta
0.56
# Stocks
5
# ETFs / Funds
0

Top Holdings (5 total)

# Symbol % Port Shares Value Avg Price Q/Q Value Chg Share Chg Chg % Status
1 ALMS 66.73% 4,528,408 $100M $22.03 $55M -91,395 -2.0%
2 ALXO 17.28% 12,884,638 $26M $2.00 $15M +3,184,713 +32.8%
3 HRMY 9.17% 489,194 $14M $28.01 -$5M — —
4 LYEL 4.53% 337,697 $7M $20.06 -$4M — —
5 ARTV 2.29% 531,337 $3M $6.44 $640K -117,170 -18.1%
View SEC EDGAR Filings for venBio Partners LLC →

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms